Annual SGA
$14.08 B
+$2.40 B+20.55%
December 1, 2024
Summary
- As of February 23, 2025, GSK annual SGA is $14.08 billion, with the most recent change of +$2.40 billion (+20.55%) on December 1, 2024.
- During the last 3 years, GSK annual SGA has risen by +$4.35 billion (+44.73%).
- GSK annual SGA is now -28.36% below its all-time high of $19.65 billion, reached on December 31, 2010.
Performance
GSK SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.41 B
-$1.54 B-31.05%
December 1, 2024
Summary
- As of February 23, 2025, GSK quarterly SGA is $3.41 billion, with the most recent change of -$1.54 billion (-31.05%) on December 1, 2024.
- Over the past year, GSK quarterly SGA has stayed the same.
- GSK quarterly SGA is now -48.05% below its all-time high of $6.56 billion, reached on December 31, 2010.
Performance
GSK Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
$41.61 B
+$560.58 M+1.37%
December 1, 2024
Summary
- As of February 23, 2025, GSK TTM SGA is $41.61 billion, with the most recent change of +$560.58 million (+1.37%) on December 1, 2024.
- Over the past year, GSK TTM SGA has increased by +$27.50 billion (+194.88%).
- GSK TTM SGA is now -27.57% below its all-time high of $57.45 billion.
Performance
GSK TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
GSK Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.6% | 0.0% | +194.9% |
| 3 y3 years | +44.7% | 0.0% | +194.9% |
| 5 y5 years | -3.3% | 0.0% | +194.9% |
GSK Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.7% | -31.1% | +40.9% | -9.0% | +78.8% |
| 5 y | 5-year | -3.3% | +47.5% | -31.1% | +401.5% | -9.0% | +632.9% |
| alltime | all time | -28.4% | >+9999.0% | -48.0% | +401.5% | -27.6% | +228.2% |
GSK Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $14.08 B(+20.5%) | $3.41 B(-31.0%) | $14.11 B(+0.6%) |
| Sep 2024 | - | $4.94 B(+59.0%) | $14.03 B(+17.0%) |
| Jun 2024 | - | $3.11 B(+17.5%) | $11.99 B(+2.3%) |
| Mar 2024 | - | $2.65 B(-20.4%) | $11.72 B(+0.4%) |
| Dec 2023 | $11.68 B(+12.6%) | $3.33 B(+14.4%) | $11.68 B(+4.1%) |
| Sep 2023 | - | $2.91 B(+2.4%) | $11.22 B(+4.5%) |
| Jun 2023 | - | $2.84 B(+9.0%) | $10.73 B(+2.3%) |
| Mar 2023 | - | $2.60 B(-9.1%) | $10.49 B(+1.7%) |
| Dec 2022 | $10.37 B(+6.6%) | $2.87 B(+18.5%) | $10.31 B(-0.9%) |
| Sep 2022 | - | $2.42 B(-6.8%) | $10.40 B(+1.0%) |
| Jun 2022 | - | $2.60 B(+6.8%) | $10.30 B(+2.3%) |
| Mar 2022 | - | $2.43 B(-17.8%) | $10.06 B(-8.3%) |
| Dec 2021 | $9.73 B(+1.9%) | $2.96 B(+27.7%) | $10.98 B(+59.3%) |
| Sep 2021 | - | $2.31 B(-1.9%) | $6.89 B(-14.1%) |
| Jun 2021 | - | $2.36 B(-29.4%) | $8.02 B(-11.1%) |
| Mar 2021 | - | $3.35 B(-395.9%) | $9.02 B(-4.2%) |
| Dec 2020 | $9.55 B(-34.4%) | -$1.13 B(-132.8%) | $9.42 B(-37.2%) |
| Sep 2020 | - | $3.45 B(+2.7%) | $14.98 B(-0.8%) |
| Jun 2020 | - | $3.36 B(-10.1%) | $15.10 B(+0.2%) |
| Mar 2020 | - | $3.74 B(-15.7%) | $15.06 B(+3.5%) |
| Dec 2019 | $14.56 B(+10.1%) | $4.44 B(+24.5%) | $14.55 B(+7.9%) |
| Sep 2019 | - | $3.56 B(+7.1%) | $13.49 B(+2.1%) |
| Jun 2019 | - | $3.33 B(+3.2%) | $13.22 B(-0.1%) |
| Mar 2019 | - | $3.23 B(-4.3%) | $13.24 B(+0.1%) |
| Dec 2018 | $13.23 B(+5.9%) | $3.37 B(+2.4%) | $13.22 B(+0.1%) |
| Sep 2018 | - | $3.29 B(-1.7%) | $13.22 B(+2.1%) |
| Jun 2018 | - | $3.35 B(+4.2%) | $12.95 B(+2.4%) |
| Mar 2018 | - | $3.21 B(-4.5%) | $12.64 B(+1.4%) |
| Dec 2017 | $12.49 B(-1.6%) | $3.36 B(+11.3%) | $12.46 B(-0.0%) |
| Sep 2017 | - | $3.02 B(-0.7%) | $12.47 B(+0.1%) |
| Jun 2017 | - | $3.04 B(+0.1%) | $12.46 B(-0.7%) |
| Mar 2017 | - | $3.04 B(-9.8%) | $12.54 B(-0.8%) |
| Dec 2016 | $12.69 B(-10.1%) | $3.37 B(+11.9%) | $12.63 B(-3.2%) |
| Sep 2016 | - | $3.01 B(-3.6%) | $13.06 B(-0.3%) |
| Jun 2016 | - | $3.12 B(-0.3%) | $13.09 B(-5.5%) |
| Mar 2016 | - | $3.13 B(-17.3%) | $13.86 B(-1.7%) |
| Dec 2015 | $14.11 B(+3.8%) | $3.79 B(+24.2%) | $14.10 B(+2.2%) |
| Sep 2015 | - | $3.05 B(-21.6%) | $13.81 B(-2.2%) |
| Jun 2015 | - | $3.89 B(+15.4%) | $14.12 B(+3.2%) |
| Mar 2015 | - | $3.37 B(-3.4%) | $13.68 B(+0.8%) |
| Dec 2014 | $13.59 B(+2.4%) | $3.49 B(+3.9%) | $13.57 B(-0.5%) |
| Sep 2014 | - | $3.36 B(-2.8%) | $13.64 B(+2.1%) |
| Jun 2014 | - | $3.46 B(+6.0%) | $13.36 B(+0.4%) |
| Mar 2014 | - | $3.26 B(-8.4%) | $13.30 B(+0.2%) |
| Dec 2013 | $13.27 B(-4.7%) | $3.56 B(+15.8%) | $13.27 B(+0.1%) |
| Sep 2013 | - | $3.08 B(-9.6%) | $13.26 B(-3.3%) |
| Jun 2013 | - | $3.40 B(+5.3%) | $13.71 B(-0.6%) |
| Mar 2013 | - | $3.23 B(-9.0%) | $13.79 B(-1.0%) |
| Dec 2012 | $13.93 B(+2.1%) | $3.55 B(+0.5%) | $13.93 B(+1.0%) |
| Sep 2012 | - | $3.53 B(+1.4%) | $13.79 B(+2.1%) |
| Jun 2012 | - | $3.48 B(+3.5%) | $13.50 B(-1.3%) |
| Mar 2012 | - | $3.36 B(-1.4%) | $13.68 B(+0.2%) |
| Dec 2011 | $13.65 B(-30.6%) | $3.41 B(+5.3%) | $13.65 B(-18.8%) |
| Sep 2011 | - | $3.24 B(-11.5%) | $16.80 B(+0.5%) |
| Jun 2011 | - | $3.66 B(+9.9%) | $16.72 B(-13.5%) |
| Mar 2011 | - | $3.33 B(-49.2%) | $19.32 B(-1.7%) |
| Dec 2010 | $19.65 B | $6.56 B(+107.7%) | $19.65 B(+9.7%) |
| Sep 2010 | - | $3.16 B(-49.5%) | $17.91 B(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | $6.26 B(+70.9%) | $18.27 B(+17.4%) |
| Mar 2010 | - | $3.66 B(-24.1%) | $15.57 B(+3.3%) |
| Dec 2009 | $15.02 B(+6.1%) | $4.83 B(+37.1%) | $15.07 B(+8.9%) |
| Sep 2009 | - | $3.52 B(-1.1%) | $13.84 B(+0.6%) |
| Jun 2009 | - | $3.56 B(+12.6%) | $13.75 B(+0.1%) |
| Mar 2009 | - | $3.16 B(-12.0%) | $13.73 B(-2.1%) |
| Dec 2008 | $14.16 B(+3.7%) | $3.59 B(+4.5%) | $14.02 B(+1.0%) |
| Sep 2008 | - | $3.44 B(-2.9%) | $13.89 B(+1.2%) |
| Jun 2008 | - | $3.54 B(+2.6%) | $13.72 B(-0.8%) |
| Mar 2008 | - | $3.45 B(-0.3%) | $13.83 B(+1.3%) |
| Dec 2007 | $13.66 B(+2.1%) | $3.46 B(+5.9%) | $13.65 B(-1.8%) |
| Sep 2007 | - | $3.27 B(-10.6%) | $13.90 B(+1.7%) |
| Jun 2007 | - | $3.66 B(+11.8%) | $13.66 B(+1.6%) |
| Mar 2007 | - | $3.27 B(-11.7%) | $13.45 B(+0.6%) |
| Dec 2006 | $13.38 B(+1.4%) | $3.70 B(+22.3%) | $13.37 B(+1.1%) |
| Sep 2006 | - | $3.03 B(-12.1%) | $13.23 B(-2.5%) |
| Jun 2006 | - | $3.45 B(+7.9%) | $13.57 B(+2.5%) |
| Mar 2006 | - | $3.19 B(-10.4%) | $13.24 B(+0.6%) |
| Dec 2005 | $13.19 B(-0.0%) | $3.56 B(+5.7%) | $13.16 B(-1.9%) |
| Sep 2005 | - | $3.37 B(+8.2%) | $13.41 B(+2.8%) |
| Jun 2005 | - | $3.12 B(+0.1%) | $13.04 B(-0.8%) |
| Mar 2005 | - | $3.11 B(-18.4%) | $13.15 B(-0.4%) |
| Dec 2004 | $13.19 B(+6.5%) | $3.81 B(+27.1%) | $13.20 B(+3.3%) |
| Sep 2004 | - | $3.00 B(-6.9%) | $12.79 B(-1.1%) |
| Jun 2004 | - | $3.22 B(+1.7%) | $12.93 B(+1.9%) |
| Mar 2004 | - | $3.17 B(-6.7%) | $12.68 B(+2.3%) |
| Dec 2003 | $12.38 B(+7322.3%) | $3.40 B(+8.1%) | $12.39 B(+37.8%) |
| Sep 2003 | - | $3.14 B(+5.7%) | $8.99 B(+2.0%) |
| Jun 2003 | - | $2.97 B(+3.3%) | $8.82 B(-0.4%) |
| Mar 2003 | - | $2.88 B(-2.9%) | $8.85 B(-14.6%) |
| Dec 2002 | $166.82 M(-98.4%) | - | - |
| Sep 2002 | - | $2.96 B(-1.5%) | $10.37 B(-0.9%) |
| Jun 2002 | - | $3.01 B(+11.8%) | $10.46 B(+0.7%) |
| Mar 2002 | - | $2.69 B(+58.1%) | $10.39 B(-3.4%) |
| Dec 2001 | $10.76 B(+6124.7%) | $1.70 B(-44.4%) | $10.75 B(+18.8%) |
| Sep 2001 | - | $3.06 B(+4.3%) | $9.05 B(+5.9%) |
| Jun 2001 | - | $2.93 B(-4.0%) | $8.55 B(+2.0%) |
| Mar 2001 | - | $3.06 B(+19.5%) | $8.38 B(+7.0%) |
| Dec 2000 | $172.79 M(+78.0%) | - | - |
| Sep 2000 | - | $2.56 B(-7.7%) | $7.83 B(+48.5%) |
| Jun 2000 | - | $2.77 B(+10.6%) | $5.27 B(+44.1%) |
| Mar 2000 | - | $2.50 B(+117.0%) | $3.66 B(+217.0%) |
| Dec 1999 | $97.09 M(+1.0%) | - | - |
| Jun 1999 | - | $1.15 B(+5.2%) | $1.15 B(+5.2%) |
| Dec 1998 | $96.13 M(+8.7%) | - | - |
| Jun 1998 | - | $1.10 B | $1.10 B |
| Dec 1997 | $88.46 M(-20.2%) | - | - |
| Dec 1996 | $110.89 M(-26.0%) | - | - |
| Dec 1995 | $149.95 M(-97.5%) | - | - |
| Jun 1995 | $5.98 B(+7896.5%) | - | - |
| Jun 1994 | $74.83 M(+0.1%) | - | - |
| Jun 1993 | $74.77 M(+1.2%) | - | - |
| Jun 1992 | $73.88 M(+7.6%) | - | - |
| Jun 1991 | $68.65 M(+8.2%) | - | - |
| Jun 1990 | $63.47 M(+42.2%) | - | - |
| Jun 1989 | $44.62 M(+154.5%) | - | - |
| Jun 1988 | $17.54 M(+91.6%) | - | - |
| Jun 1987 | $9.15 M(+27.1%) | - | - |
| Jun 1986 | $7.20 M | - | - |
FAQ
- What is GSK annual SGA?
- What is the all time high annual SGA for GSK?
- What is GSK annual SGA year-on-year change?
- What is GSK quarterly SGA?
- What is the all time high quarterly SGA for GSK?
- What is GSK quarterly SGA year-on-year change?
- What is GSK TTM SGA?
- What is the all time high TTM SGA for GSK?
- What is GSK TTM SGA year-on-year change?
What is GSK annual SGA?
The current annual SGA of GSK is $14.08 B
What is the all time high annual SGA for GSK?
GSK all-time high annual SGA is $19.65 B
What is GSK annual SGA year-on-year change?
Over the past year, GSK annual SGA has changed by +$2.40 B (+20.55%)
What is GSK quarterly SGA?
The current quarterly SGA of GSK is $3.41 B
What is the all time high quarterly SGA for GSK?
GSK all-time high quarterly SGA is $6.56 B
What is GSK quarterly SGA year-on-year change?
Over the past year, GSK quarterly SGA has changed by $0.00 (0.00%)
What is GSK TTM SGA?
The current TTM SGA of GSK is $41.61 B
What is the all time high TTM SGA for GSK?
GSK all-time high TTM SGA is $57.45 B
What is GSK TTM SGA year-on-year change?
Over the past year, GSK TTM SGA has changed by +$27.50 B (+194.88%)